Sotera Health (SHC) Stock Price & Analysis
Score
AI Analysis
SnapshotSotera Health is a mixed profile at 62/100 — Value 51, Growth 68, Quality 66. Under the hood: P/E 31.7, about 63% below its own multi-year median, plus revenue compounding ~5% annually over recent years.
Price History
Price: —
Fair value: —
—
P/E (TTM): —
Net Income (TTM): —
Score: —
—
Score Breakdown
Market percentile scores loading…
Value
Growth
Quality
Financial Summary
Sotera Health Company (SHC) last printed $16.61. Equity value is $4.74B. Trailing earnings multiple 29.04. The revenue row is reported history. Targets and ratings are on the forecast page.
Financials
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| $746.15M | $778.33M | $818.16M | $931.48M | $1B | $1.05B | $1.1B | $1.16B |
About
Sotera Health Company, headquartered in Broadview Heights, Ohio, delivers essential sterilization, laboratory testing, and advisory services to a global clientele spanning North America, Europe, and various international regions. The firm's sterilization capabilities encompass gamma and electron beam irradiation, alongside ethylene oxide (EO) processing. Through its Nelson Labs division, Sotera Health conducts comprehensive microbiological and analytical chemistry analyses. Additionally, it offers specialized consulting to the medical device and biopharmaceutical industries. Sotera Health serves a diverse array of sectors, including medical device manufacturers, pharmaceutical companies, producers of food and agricultural products, and various commercial, advanced, and specialty application industries. Incorporated in 2017, the company was previously known as Sotera Health Topco, Inc., adopting its current name in October 2020.